IGF1 and type 1 diabetes mellitus: Microglial IGF-1 levels were reduced in type 1 diabetic mice (T1DM) mice, and the activation of spinal IGF-1 signaling maintained microglial IGF-1 expression in the spinal cord of diabetic mice and reduced neuro-inflammation (Chen et al., 2022).